Belimumab, a monoclonal antibody, added to standard therapy may treat a broader range of patients with lupus nephritis than previously appreciated.

Early diagnosis and treatment of generalized myasthenia gravis (MG) are important to achieve symptomatic control and limit relapses, but evidence suggests social resources may be not applied to this ...